John Thomas, MD
Hematology & Oncology · Newnan, GANPI 1306342076
Payments from drug & device makers
Across 20 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$110
- AbbVie$67
- Tersera Therapeutics LLC$32
- Regeneron Healthcare Solutions, Inc.$26
- Novartis$26
- CSL Behring$25
- plus $208 from 11 others
What the payments were for
- Food & beverage$495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 2 | $110 |
| AbbVie | 3 | $67 |
| Tersera Therapeutics LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Novartis | 1 | $26 |
| CSL Behring | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Fennec Pharmaceuticals, Inc. | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
How this compares
$495 in reported general payments places this provider in the 15th percentile of 370 hematology & oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 14 | $173 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Newnan
- Vasileios AssikisNewnan$3.1M
- Nitika SharmaNewnan$411K
- Bamidele AdesunloyeNewnan$343K
- Mehmet BilenAtlanta$21.7M
- Steven McCuneMarietta$19.5M
- Ajay NookaAtlanta$19.3M
- Olatunji AleseAtlanta$15.5M
- Jonathon CohenAtlanta$8.7M
- Ticiana LealAtlanta$6.1M
- Amelia ZelnakCumming$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.